nanoparticle-mcDNA co-delivery in the microspheres.Overall these findingssupport the concept of using nanoparticle-microsphere multipart systemsto achieve efficient co-delivery of various drug-mcDNA combinations.
Gas-generating TPGS

Introduction
In the last decades the relativeineffectiveness of clinically administered anti-cancer therapeutics hashighlightedthenecessity todevelop novel treatments that can improve cancer prognosis and patient survival rates [1] . To deal with this unfavorable scenario efforts are being focused on the combinatorialadministration ofmultiple bioactive moleculessuch as:
i.)anti-tumoral drugs, ii.) proteins, iii.) natural compounds, iv.) antibodies andv.) nucleic acids (e.g. DNA, RNA), as a strategy to achieve an improved therapeutic effectin comparison to stand-alone treatments [2] . Fromall combinatorialtherapies, thosebased on drug-DNA coadministration have shown to be particularly promising for targeting multiple cancer hallmarks [3] [4] [5] .
Chemotherapy-nucleic acid combinations generally take advantage of drugs intrinsic antitumoral activity together withDNAcapacity to surpassadditionalgenetic abnormalities of cancer cells. Such coordinated action isexpectedtoresult in a synergistic effect, and ultimately, in tumor regression [5, 6] .Despite its remarkable potential, thistreatment modality remainslimited bydrugssystemic cytotoxicity and by the establishment of cell drug resistance due toexocytosisvia drug efflux pumps [7] .Adding to this fact,standard non-viral DNA expression vectors are unstable in blood circulationand relativelyineffective in promoting prolonged gene expressionin vivo [8, 9] . These factorsaffect the feasibility of co-administering free drugs and naked DNA through the various administration routes (e.g. intravenous, oral)and contribute for the reduced application of combinatorial therapies in the clinic.
A valuablestrategy to overcome thesedrawbacks is the formulation of micro and nanoparticlesthat can transpose biological barriers and deliver small molecule-gene combinations into unhealthy cells.To loadmultipletherapeutics simultaneously the delivery systems mustdisplay hydrophilic or hydrophobic character for drug encapsulation and positively charged groups for DNA condensation [10] .Designing micro or nanocarriers with such versatileproperties remains highly challenging, and to date very few materialsexhibitedsuitable physicochemical properties to achieve this goal. In this context, Zhang and co-workers, used peptide-functionalized DSPE/PEG liposomes to perform the codelivery of Paclitaxel and microRNA antagomir-10b (miRNA-10b) in order to delay tumor growth and lung metastasis dissemination [11] . Recently,triblock copolymermicellar delivery systems for co-delivery of Doxorubicin (Dox) and minicircle DNA (mcDNA) have been developed in our group to attain an improved therapeutic effect [10] . mcDNA was selected, as exogenous gene expression vector, because it is devoid ofbacterial backbone,which is responsible for inducing transgene silencing and eliciting severe immunological responses from the host [12] . Besides, mcDNA provides higher levels of transgene expression both in vitro and in vivo in comparison with standard DNA [13] . While these drug-gene co-delivery studiesreveal a positive outcome from dual administration via nanodevices,the release of therapeutics was not actively controlled. Manipulating drug or gene release in a spatially and temporally controlled mode at the target siteis crucialfor further improvingcarriersbiological performance andmaximize the efficacy ofcombinatorial therapy [2, 14] .
Stimuli-responsive carriersare aviable option to fulfill this purpose since cargo release can be promoted by different extracellular and intracellular signals [15, 16] .Redox potential variation, enzymes, light, temperature and pHare some of the stimulus that can be exploited for creating dynamic delivery systems that sense and react to their surrounding environment [17, 18] .Response to pH changes is a particularly valuable strategy for cancer therapy sinceacid-triggered release can be promoted at the tumor microenvironment and in cancer cells lysosomal compartments [19] . Gas-generating pH-sensitive carriers are anadvanced class ofefficient stimuli-sensitive delivery systems that generate carbon dioxide gas (gCO 2 ), as a response to surrounding acidic environments. Such gas production is generally mediated by bicarbonate salts (sodium bicarbonate (NaHCO 3 ), or ammonium bicarbonate (NH 4 HCO 3 )),that are encapsulated inside the delivery systems. The pH responsiveness is conferred by the reaction between hydrogencarbonate anion (HCO 3 -) with acid medium,whichin turnproduces gCO 2 bubbles that trigger the formation of pores in particles shell and cargo release [19] . The therapeutic applicability of gCO 2 -based pHresponsive systems was recently demonstrated by Liu and co-workers with the delivery of NH 4 HCO 3 and Dox-loaded Cholesterol-mPEG 2000 -DSPE liposomes [20] . The delivery of pHsensitive liposomes to multi-drug resistant (MDR) breast cancer cells resulted in an increased intracellular drug concentration and improved cytotoxic activity [20] . To the best of our knowledge such gas-triggered delivery systemsare yet to be explored for dug-mcDNA combinatorial therapy.
Therefore, this study reports the successfulformulation of nanoparticle-in-microsphere hybrid delivery systems (NIMPS) based on pH-responsive TPGS-PLGA microspheres and amino acid modified chitosan nanoparticles as a strategy for promoting the dual delivery of mcDNA and Dox to cancer cells. In this multipart system amino acid-modified chitosan nanoparticles providecomplexation of mcDNA gene expression vectors.Modification of chitosan with amino acids, namely L-histidine and L-arginine,further grants the polymer backbone a pH-responsive capacity as our group previously reported [21] . This functionalization enhances nanocarriers biological performance, as well asgene expression efficiency [21] ,making it a good candidate for mcDNA delivery to cancer cells. The rationale of furtheremploying TPGS as a coatingfor gas-generating PLGA-NaHCO 3 microcarriers is established on previous evidence that this polymerenhances both cellular uptake and particles stability in physiological medium in comparison to standard poly(vinyl alcohol) (PVA) [22] .Overall, our findings demonstrate that the use of FDA approved, TPGS and PLGA biodegradable polymers as materials for microparticles production assures the biocompatibility of the NIMPS system and its potential for translation to therapy.Moreover, NIMPSdemonstrated a gas-mediated pH-sensitive drug release in acidic medium and an improved cellular uptake in cancer cells. Transgene expression mediated by mcDNA vectors was confirmed after nanoparticle delivery, corroborating the co-administration concept. As a final point,Dox delivery in NIMPS resulted in a cytotoxic effect comparable to that of free drug, a result that demonstrates the potential of using this multipart system for co-delivery of different mcDNA-chemotherapeutics combinations.
Materials and Methods'
For a detailed description of the materials and methods the reader is referred to the electronic supplementary information.
Methods
Preparation of Doxorubicin-loaded gas-generating hollow microspheres
PLGA and TPGS-PLGA hollowmicrospheres were formulatedby using the water-in-oil-inwater double-emulsion solvent diffusion-evaporation method reported byKe and co-workers with slight modifications [19] .Blank microparticles were prepared by the W/O/W method without Dox incorporation in the first aqueous phase. Dox-loaded microspheres with PVA or TPGS coating are termed micro-PVA-Dox and micro-TPGS-Dox, respectively.
Preparation of mcDNA Amino acid-Chitosan nanoparticles
Prior to preparation of chitosan-mcDNA nanoparticles the cationic biopolymer was chemically modified with L-arginine and L-histidinevia EDC/NHS coupling chemistry to yield multifunctional Chitosan-Arginine-Histidine (CH-HR)as our group previously reported [21] .All nanoparticles were formulated at the amine-to-phosphate ratio of 60 (N/P 60) since this formulation has previously presented optimal stability, biological performance and transfection efficiency [21] . mcDNA complexation by CH-HR was confirmed by agarose gel electrophoresis [23] . Nanocarriers loading into Micro-TPGS-Dox microspheres was accomplished by adding CH-HR-mcDNA nanoparticles in the primary aqueous phase of the W/O/W assembly process. The resulting Micro-TPGS-Dox-(CH-HR-mcDNA) nanoparticle-inmicrosphere systems are designated by NIMPS from herein onwards.
Delivery systems physicochemical characterization
Microspheres and nanoparticlessizewasanalysed by Dynamic Light Scattering (DLS) in a ZetasizerNanoZS (Malvern Instruments, Worcestershire, UK). Three independent measurements were performed indisposable folded capillary cells (DTS1070), at 25ºC, and with a 173°scattering angle.Microspheres morphology wasevaluated by scanning electron microscopy (SEM) by using a Hitachi S-3400N scanning electron microscope(Hitachi, Japan).The existence of the gas-generating agent (NaHCO 3 ) in PLGA microspheres core was determined by X-ray diffraction spectroscopy (XRD).
Drug encapsulation and in vitro release
Drug encapsulation efficiency in allPLGA microsphere formulations was determined through UV-vis spectrophotometry at λ=485nm by using aShimadzu-1700spectrophotometer
(Shimadzu Inc., Japan). Drug encapsulation efficiency was calculatedas reported in the literature [24] .Drug release from microspheres was evaluated by the dialysis method, in duplicate independent experiments. Drug release was carried out at 37 ºC in a water bath, with magnetic stirring (500 rpm), in the dark. Supernatant samples were collected at various time-pointsand the drug content was analyzed by UV-vis spectrophotometry.
Cellular uptake
The cellular uptake of drug-loaded microparticles (micro-PVA-Dox, micro-TPGS-Dox) and 
2.1.6.In vitro gene expression in 2D cultures
mcDNA-GFP expression in cancer cells was evaluated by spectrofluorimetry [23] .For this assay,HeLa cells were cultured in 96 well black-clear bottom plates at a density of 1 x 10 4 cells per well. Gene expression was quantified after 48 hby using a plate readerspectrofluorometer(Spectramax Gemini XS, Molecular Devices LLC, USA), atλ ex =488 nm and λ em =519 nm.In addition, GFP expression was also visualized and quantifiedby CLSM by using a Zeiss LSM 710 confocal microscope (Carl Zeiss SMT Inc., USA), equipped with a Plan-Apochromat 63x/1.4 oil objective.For all experiments, 3D z-stacks of randomly distributed cell fields (n=3) were acquired. GFP fluorescence intensity in cells volume was quantified by using the Imaris software(Bitplane, Switzerland).
Cytotoxic activity
The cytotoxic activity of Dox-loaded microspheres and mcDNA-Dox dual loaded NIMPSwas evaluated by the MTS assay as previously described [10] . Dead cells (70 % EtOH), and nontreated cells were used as positive and negative controls, respectively.
2.1.8.Statistical analysis
One-way analysis of variance (ANOVA) with the post-hoc Newman-Keuls test were used for statistical analysis of three or more groups. Student's t-test was used for comparison between two groups. A p value below 0.05 was considered statistically significant.
Results and Discussion
Formulation of Gas-generating PLGA Microspheres
Gas-generating pH responsive hollow PLGA microspheres were produced by the double emulsion water-on-oil-water (W/O/W) solvent diffusion-evaporation methodas schematized in supplementary Figure S1A . Initially thefirstwater phase comprised by the gas-generating agent (sodium bicarbonate, (NaHCO 3 ))and bythe PVA surfactant, were mixed with the oil phase containing PLGA dissolved in dichloromethane. Primaryemulsification was promoted by the action of ultrasound waves which generated well-defined PLGA droplets by disrupting the oil-water interface.
The resulting microcarriers were subsequently mixed with the second water phase comprised either by PVA or TPGS ( Figure S1A ). TPGS was used as an alternative to PVA for microspheres production because the PLGA-NaHCO 3 -PVA-PVA systemsgenerally described in the literature have shown relatively low cellular uptake and also reduced stability in biological fluids [25] . Thus,as a strategy to improvemicrocarriers biological performance, TPGS was used as the surfactant in a second emulsification that involves high speed homogenization (supplementary Figure S1A) . Following the successful formulation of TPGS coated PLGA microspheres the presence of the gas-generating agent in the carriers was analyzed by X-ray diffraction. As demonstrated in Figure 2A thecharacteristic peaks of NaHCO 3 crystalline structureare presentin microsphere formulations,indicating the effective encapsulation of the bicarbonate salt in particles during the assembly process. The broad XRD peak centered at 2Θ ~ 19.5° is assigned to amorphous PLGA microspheres ( Figure 1A) . Interestingly, no significant differences in NaHCO 3 characteristic diffraction peaks is observed between micro-PVA and micro-TPGS formulationssuggesting that the addition of TPGS in the end of the process does not affect NaHCO 3 encapsulation. (supplementary Figure S2A and B).Microspheres surface charge is also changed upon drug encapsulation in micro-PVA-Doxand micro-TPGS-Dox formulations, with the latter presenting a neutral zeta potential (ζ =-9.17 mV). This neutrality is highly important for the therapeutic efficiency of micro or nanoparticle formulations since it has been previously demonstrated that particles zeta potential in the range of neutrality (+10 mV to -10 mV) achieve optimal for tumor penetration [27] .
Microcarriers biological characterization
To further characterize the biological properties of micro-sized delivery systems, in vitro Figure 2D , white arrows; supplementary figure S4, E1 and E2). We hypothesize that such difference is correlated with the enhanced cellular uptake efficiency of micro-TPGS-Dox carriers. From a therapeutic point of view achieving this increased intracellular concentration and nuclear localization is critical for improving the overall therapeutic efficacy as Dox intracellular targets are mainly localized in the nuclear compartment [29] . The cellular uptake of microcarriers with this hydrodynamic size has also been reported in the literature [25] . In fact, the interesting work of Ke et al, explored the cellular uptake routes of PLGA-PVA microspheres, revealing that this event is an energy dependent process and that macropynocytosis plays a significant role in microcarriers internalization [25] .
Stimuli-responsivedrug release
Since TPGS-based microcarriers present an improved cellular uptake efficiency, their responsiveness to acidicmilieu was investigated. Eventually the resulting gCO 2 bubbles diffuse through particles shelland originatepores whichstimulate a rapid release of the anti-tumoral drug (Figure 3 B) .Drug release assays were performed both in physiological and acidic conditions in an attempt to mimic a stimulicontrolled drug release in the acidic tumor microenvironment or acidic cell compartments. As the results demonstrate the immersion of TPGS-coated PLGA microspheres in acidic medium results in a rapid and extensive Dox release ( Figure 3A) . In fact, the particles that were exposed to pH=5.6 exhibit a 3.88-fold higher drug release at 8 h, when compared to their equivalents immersed in physiological conditions (pH = 7.4) ( Figure 4A ). This tendency is also maintained after 70 h of incubation. It is important to emphasize that at physiological pH the microcarriers have negligible burst releasesince only 13 % of loaded drug is released at 30 h (Figure 3 A) . Retention of the anti-tumoral drug in the particles core is crucial to reduce off-target cytotoxic effects upon their administration in vivo [14] .
Additionally, SEM imaging was used to complement the characterization of microsphere structural stability in environments with different pH. The results in supplementary Figure   S5show that micro-TPGS carriers preserve their structural and morphological integrityupon incubation in physiological conditions, whilemicrospheres exposed to acidic mediumdisplay various holes in their shell due to the effervescent reaction promoted by NaHCO 3 and acid (White square, supplementary Figure S5B2 and B3). Particles disintegration is also confirmed by the significant amount of free polymer present in SEMmicrographs (supplementary Figure S5 B1 to B3, white arrows).Such findingsconfirm the stimuliresponsive profile ofmicro-TPGS particles,contributing for the envisioned control overdrug release at the target tumor site.
Formulation of drug-gene loaded pH-responsive PLGA Microspheres (NIMPS)
Since TPGS-coated microcarriers demonstrate a pH-responsive profile and also an improved cellular uptake, the co-delivery of drugs and genes was investigated by combining micro-TPGS-Dox with mcDNA-loaded amino acid chitosan (CH-HR) nanoparticles as a strategy to promote the dual delivery of these therapeutics (schematics of Figure 4 ). Toconfirm the presence of mcDNA nanoparticles inside the PLGA microcarriers,the dual system was also analyzed by confocal microscopy. As displayed in Figure 4 
NIMPS cellular uptake and gene expression
The cellular uptake analysis of NIMPS demonstrates that the hybrid carriers exhibit higher To complement NIMPS characterization the gene expression mediated by mcDNA-GFP when co-delivered with Dox was assessed. The results demonstrate that GFP expression achieved by CH-HR-mcDNA nanoparticles is slightly higher thanthatobtained with NIMPS.
However, this difference is not significant (supplementary Figure S8 E and F) , and may be attributed to the fact that mcDNA-nanoparticles must be released from microcarriersbefore being localized in the cytoplasmas emphasized by Shardool and co-workers that developed nanoparticle-in-microsphere systems for oral delivery [33] . Besides, these results demonstrate that mcDNA-nanoparticles delivered in NIPMS achieve successful GFP expression.
Delivery systems cytotoxic activity
The cytotoxic activity of both single and dual-loaded delivery systems produced throughout this study was investigated to provide evidence aboutNIMPS therapeutic potential. of mcDNA non-viralvectors, which are reported to be more effective than standard DNA both in vitro and in vivo [9] .From a therapeutic point of view this is a crucial factor since cancer treatment may be improved by using mcDNA vectors that encode anti-tumoral genes (e.g.
P53 or TRAIL [34, 35] ), and combining their action with the cytotoxic activity of chemotherapeutics, to achieve a synergistic anti-tumoral effect.
PLGA-NaHCO 3 -PVAbased microspheres for Doxdelivery to cancer cells have been previously described in the literature [25] . Herein, we have taken advantage of this simple and cost-effective technology to formulate pH-responsive microspheres with further improved cellular uptake, and also demonstrated the possibility to efficiently co-delivery nanoparticlemcDNA in these systems. Due to its stability NIMPS provide the possibility to be locally delivered to cervix cancer location and respond to the acidic pH of this tumor [36, 37] . This is a major advantage when compared as example to other nanoparticulated PLGA-based systems (PLGA-PEI) for co-delivery and which require chemical modifications for being able toencapsulate drugs and genes and are unable to respond to extracellular stimuli [38] . The micron-size of the NIMPS system may prove beneficial in the future for inclusion in tandem or ovoid devices that are generally used in the clinics to locallyapplytreatment for this particular type of cancer [39] . In addition, the recently described potential of using gas generation fortheranostic applications based in ultrasound imaging further expands the applicability of these carriers [40] .
Conclusions
In summary, in this study we have developed a pH-responsive nanoparticle-in-microsphere hybrid delivery system comprised by gas-generating PLGA-TPGS-Dox microcarriers and byamino acid chitosan nanoparticles loaded with mcDNA vectors. This multipart delivery platform has proven to respond to acidic pH and release its cargo in a spatiotemporally controlled mode. micro-TPGS-Dox microspheres have also displayed an improved cellular uptake in comparison to standard PLGA-PVA microcarriers. Adding to this, the concept of using nanoparticles inside microspheres for combinatorial therapy was supported by the evidence that the resulting NIMPS formulations have the highest cellular uptake, accomplish transgene expression, and above all exhibit an improved cytotoxic activity. It is also important to emphasize that to the best of our knowledge this was the first time that mcDNA-loaded nanoparticles were included in PLGA microspheres as a strategy to co-deliver anti-tumoral drugs and genetic material. NIMPS are in fact a valuable addition to the relatively few number of delivery systems that are currently capable of delivering DNA minicircles and chemotherapeutics simultaneously. In fact, considering the drawbacks associated with standalone cancer treatments such as those based on single drug administration these findings encourage the applicability of this hybrid system for exploring new drug-gene combinations and to bridge the gap between pre-clinical research and realistic clinical application.
In the future the versatility of PLGA microspheres to encapsulate both hydrophilic/hydrophobic drugs and the possibility of including cancer cell targeting biomolecules in TPGS structure will surely prove to be beneficial for the development of a delivery platform that is based on FDA approved materials. Additionally, 3D tumor spheroids can be used in the future for testing the therapeutic efficiency of NIMPS in high-throughput models that more closely mimic in vivo tumors. 
